Trustworthy and Self-explanatory Artificial Intelligence for the Classification of Non-Hodgkin Lymphoma by Immunophenotype

Author:

Thrun Michael1ORCID,Hoffmann Jörg2,Krause Stefan3ORCID,Weit Nicole4,Krawitz Peter5,Stier Quirin6ORCID,NEUBAUER Andreas1ORCID,Brendel Cornelia1,Ultsch Alfred7

Affiliation:

1. Philipps University Marburg

2. Department of Hematology, Oncology and Immunology, Philipps University Marburg

3. Universitätsklinikum Erlangen

4. Beckman Coulter Inc, Global Strategic Marketing Flow Cytometry Business Unit

5. University Hospital Bonn

6. Mathematics and Computer Science, Philipps University Marburg, Hans-Meerwein-Strasse 6, 35032 Marburg, Germany

7. Mathematics and Computer Science, Philipps University Marburg

Abstract

Abstract

Diagnostic immunophenotyping of malignant non-Hodgkin-lymphoma (NHL) by multiparameter flow cytometry (MFC) relies on highly trained physicians. Artificial intelligence (AI) systems have been proposed for this diagnostic task, often requiring more learning examples than are usually available. In contrast, Flow XAI has reduced the number of needed learning data by a factor of 100. It selects and reports diagnostically relevant cell populations and expression patterns in a discernable and clear manner so that immunophenotyping experts can understand the rationale behind the AI’s decisions. A self-organized and unsupervised view of the complex multidimensional MFC data provides information about the immunophenotypic structures in the data. Flow XAIintegrates human expert knowledge into its decision process. It reports a self-competence estimation for each case and delivers human-understandable explanations for its decisions. Flow XAI outperformed comparable AI systems in qualitative and quantitative assessments. This self-explanatory AI system can be used for real-world AI lymphoma immunophenotyping.

Publisher

Research Square Platform LLC

Reference63 articles.

1. Bruggner RV, Bodenmiller B, Dill DL, Tibshirani RJ, Nolan GP (2014) Automated identification of stratifying signatures in cellular subpopulations. Proc. Natl. Acad. Sci. U. S. A. 111, E2770–E2777

2. New interpretable machine-learning method for single-cell data reveals correlates of clinical response to cancer immunotherapy;Greene E;Patterns,2021

3. Enhanced flowType/RchyOptimyx: a bioconductor pipeline for discovery in high-dimensional cytometry data;O’Neill K;Bioinformatics,2014

4. Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping;Hoffmann J;Cytometry B Clin Cytom,2020

5. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes;Dongen J;Leukemia,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3